UPMC - Center for Liver Diseases at the Thomas E. Starzl Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
UPMC - Center for Liver Diseases at the Thomas E. Starzl Institute has participated in 2 clinical trials.
Therapeutic areas: Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease.
Sponsors: Intercept Pharmaceuticals, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Pittsburgh
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC - Center for Liver Diseases at the Thomas E. Starzl Institute has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC - Center for Liver Diseases at the Thomas E. Starzl Institute has 2 clinical trials on record. Their work covers Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease.
UPMC - Center for Liver Diseases at the Thomas E. Starzl Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.